Significant Ownership of Lincoln Alternative Strategies LLC

Signature - Title
/s/ Stephen Temes - Stephen Temes/Managing Member
Location
Miami Beach, FL
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Lincoln Alternative Strategies LLC.

Notify me when Lincoln Alternative Strategies LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Lincoln Alternative Strategies LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PPBT PURPLE BIOTECH LTD. American Depositary Shares, each representing 200 Ordinary Shares 9.9% $1,288,650 605,000 Lincoln Alternative Strategies LLC 04 Sep 2025
XRTX XORTX Therapeutics Inc. Common Shares, no par value per share 9.9% $498,049 572,470 Lincoln Alternative Strategies LLC 23 Oct 2025
BCDA BioCardia, Inc. Common Stock, par value $0.001 per share 7.5% $1,560,000 800,000 Lincoln Alternative Strategies LLC 19 Sep 2025
CVM CEL-SCI Corporation Common Stock, par value $0.01 per share 6.9% $4,761,900 555,000 Lincoln Alternative Strategies LLC 27 Aug 2025
SSKN STRATA Skin Sciences, Inc. Common Stock, $0.001 par value 6.9% $695,113 365,849 Lincoln Alternative Strategies LLC 03 Sep 2025
SLXN Silexion Therapeutics Corp. Ordinary Shares, par value $0.0009 per share 6.2% $115,500 131,250 Lincoln Alternative Strategies LLC 12 Sep 2025
BNGO Bionano Genomics, Inc. Common Stock, par value $0.0001 per share 5.4% $2,021,250 525,000 Lincoln Alternative Strategies LLC 17 Sep 2025
VMAR Vision Marine Technologies Inc. Common stock, no par value per share 4.3% $6,454 -$106,046 43,028 -94% Lincoln Alternative Strategies LLC 14 Jan 2026
GRI GRO Bio, Inc. Common stock, par value $0.0001 per share 0% $0 -$263,506 0 -100% Lincoln Alternative Strategies LLC 30 Dec 2025
CLDI Calidi Biotherapeutics, Inc. Common stock, par value $0.0001 per share 0% $0 -$817,600 0 -100% Lincoln Alternative Strategies LLC 18 Sep 2025
CELU Celularity Inc. Class A Common Stock, $0.0001 par value per share 0% $0 0 Lincoln Alternative Strategies LLC 14 Jul 2025
JAGX Jaguar Health, Inc. Common stock, par value $0.0001 per share 0% $0 -$150,000 0 -100% Lincoln Alternative Strategies LLC 12 Jan 2026
LGVN Longeveron Inc. Common stock, par value $0.0001 per share 0% $0 -$647,058 0 -100% Lincoln Alternative Strategies LLC 13 Aug 2025

Schedules 13D/G Reported by Lincoln Alternative Strategies LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.